Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
RSI : 000
CBHD.DE Stock Summary
Top 10 Correlated ETFs
CBHD.DE
In the News
CBHD.DE Financial details
Company Rating
Strong Buy
Market Cap
27.75B
Income
4.87B
Revenue
25.05B
Book val./share
69.22
Cash/share
4.19
Dividend
21
Dividend %
2.69%
Employees
15.75K
Optionable
No
Shortable
Yes
Earnings
07 May 2024
P/E
36.7
Forward P/E
4.45
PEG
94.48
P/S
7.18
P/B
10.15
P/C
29.58
P/FCF
48.2
Quick Ratio
0.06
Current Ratio
0.61
Debt / Equity
1.43
LT Debt / Equity
0.81
-
-
EPS (TTM)
23
EPS next Y
27.84
EPS next Q
5.8
EPS this Y
0.32%
EPS next Y
21.03%
EPS next 5Y
82.77%
EPS last 5Y
4.02%
Revenue last 5Y
6.43%
Revenue Q/Q
6.1%
EPS Q/Q
-4.26%
-
-
-
-
SMA20
2.46%
SMA50
16.82%
SMA100
23.76%
Inst Own
0.01%
Inst Trans
1%
ROA
10%
ROE
51%
ROC
0.21%
Gross Margin
66%
Oper. Margin
27%
Profit Margin
20%
Payout
111%
Shs Outstand
222.29M
Shs Float
152.31M
-
-
-
-
Target Price
-
52W Range
92.5-132.75
52W High
-6.1%
52W Low
+34.73%
RSI
54
Rel Volume
0.04
Avg Volume
475
Volume
18
Perf Week
0.85%
Perf Month
4.42%
Perf Quarter
25.1%
Perf Half Y
22.78%
-
-
-
-
Beta
0.292
-
-
Volatility
0.67%, 3.06%
Prev Close
-1.39%
Price
123.95
Change
-0.88%
CBHD.DE Financial Performance
Yearly Fundamentals Overview
Last date of statement is 2023-09-30
Metric | History | 2019-09-30 | 2020-09-30 | 2021-09-30 | 2022-09-30 | 2023-09-30 |
---|---|---|---|---|---|---|
2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
Revenue per share | 84.5 | 87.22 | 91.29 | 106.25 | 113.74 | |
Net income per share | 18.24 | 19.74 | 22.67 | 22.15 | 22.21 | |
Operating cash flow per share | 20.52 | 22.38 | 24.86 | 24 | 19.62 | |
Free cash flow per share | 17.53 | 18.01 | 15.62 | 18.65 | 13.86 | |
Cash per share | 3.15 | 2.75 | 3.17 | 2.98 | 4.23 | |
Book value per share | 32.56 | 34.84 | 38.38 | 39.02 | 80.31 | |
Tangible book value per share | 20.78 | 23.72 | 21.23 | -56.4 | -64.79 | |
Share holders equity per share | 32.56 | 34.84 | 38.38 | 39.02 | 80.31 | |
Interest debt per share | 5.72 | 8.36 | 13.21 | 88.85 | 93.8 | |
Market cap | 175.94B | 216.29B | 217.67B | 164.1B | 161.44B | |
Enterprise value | 176.79B | 217.72B | 220.01B | 182.39B | 180.09B | |
P/E ratio | 45.43 | 51.54 | 45.11 | 34.87 | 33.75 | |
Price to sales ratio | 9.81 | 11.66 | 11.21 | 7.27 | 6.59 | |
POCF ratio | 40.38 | 45.45 | 41.15 | 32.18 | 38.2 | |
PFCF ratio | 47.28 | 56.5 | 65.48 | 41.4 | 54.08 | |
P/B Ratio | 25.45 | 29.21 | 26.65 | 19.79 | 9.33 | |
PTB ratio | 25.45 | 29.21 | 26.65 | 19.79 | 9.33 | |
EV to sales | 9.86 | 11.74 | 11.33 | 8.08 | 7.35 | |
Enterprise value over EBITDA | 28.46 | 33.79 | 30.42 | 23.19 | 23.3 | |
EV to operating cash flow | 40.58 | 45.75 | 41.59 | 35.77 | 42.62 | |
EV to free cash flow | 47.51 | 56.87 | 66.19 | 46.01 | 60.33 | |
Earnings yield | 0.02 | 0.02 | 0.02 | 0.03 | 0.03 | |
Free cash flow yield | 0.02 | 0.02 | 0.02 | 0.02 | 0.02 | |
Debt to equity | 0.17 | 0.24 | 0.34 | 2.26 | 1.13 | |
Debt to assets | 0.09 | 0.13 | 0.18 | 0.54 | 0.41 | |
Net debt to EBITDA | 0.14 | 0.22 | 0.32 | 2.33 | 2.41 | |
Current ratio | 1.29 | 1.3 | 1.11 | 1.2 | 0.61 | |
Interest coverage | 859.33 | 195.13 | 254.2 | 37.44 | 10.61 | |
Income quality | 0.85 | 0.81 | 0.86 | 0.79 | 0.62 | |
Dividend Yield | 0.02 | 0.02 | 0.02 | 0.02 | 0.03 | |
Payout ratio | 0.88 | 0.86 | 0.79 | 0.86 | 0.89 | |
Sales general and administrative to revenue | 0.04 | 0.04 | 0.04 | 0.04 | 0.05 | |
Research and developement to revenue | 0.04 | 0.04 | 0.04 | 0.04 | 0.04 | |
Intangibles to total assets | 0.2 | 0.18 | 0.23 | 0.58 | 0.65 | |
Capex to operating cash flow | -0.15 | -0.2 | -0.37 | -0.22 | -0.29 | |
Capex to revenue | -0.04 | -0.05 | -0.1 | -0.05 | -0.05 | |
Capex to depreciation | -0.98 | -1.09 | -2.48 | -1.22 | -1.16 | |
Stock based compensation to revenue | 0 | 0 | 0 | 0 | 0 | |
Graham number | 115.61 | 124.39 | 139.93 | 139.44 | 200.31 | |
ROIC | 0.48 | 0.46 | 0.42 | 0.18 | 0.14 | |
Return on tangible assets | 0.38 | 0.38 | 0.4 | 0.32 | 0.28 | |
Graham Net | -8.57 | -10.32 | -15.86 | -101.09 | -115.84 | |
Working capital | 1.42B | 1.51B | 680M | 1.44B | -6.37B | |
Tangible asset value | 4.41B | 5.04B | 4.52B | -11.99B | -13.96B | |
Net current asset value | 540M | 396M | -679M | -17.89B | -20.92B | |
Invested capital | 0.17 | 0.24 | 0.34 | 2.26 | 1.13 | |
Average receivables | 1.58B | 3.04B | 3.07B | 3.58B | 4.13B | |
Average payables | 805M | 836.5M | 925M | 1.14B | 1.27B | |
Average inventory | 1.83B | 2.08B | 2.33B | 2.81B | 3.35B | |
Days sales outstanding | 64.15 | 57.75 | 60.35 | 63.69 | 64.28 | |
Days payables outstanding | 54.19 | 50.09 | 61.86 | 64.3 | 57.8 | |
Days of inventory on hand | 121.94 | 137.03 | 144.97 | 165 | 157.31 | |
Receivables turnover | 5.69 | 6.32 | 6.05 | 5.73 | 5.68 | |
Payables turnover | 6.74 | 7.29 | 5.9 | 5.68 | 6.32 | |
Inventory turnover | 2.99 | 2.66 | 2.52 | 2.21 | 2.32 | |
ROE | 0.56 | 0.57 | 0.59 | 0.57 | 0.28 | |
Capex per share | -3 | -4.38 | -9.24 | -5.34 | -5.76 |
Quarterly Fundamentals Overview
Last date of statement is 2023-12-31 for Q1
Metric | History | 2022-12-31 | 2023-03-31 | 2023-06-30 | 2023-09-30 | 2023-12-31 |
---|---|---|---|---|---|---|
2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
Revenue per share | 28.54 | 28.76 | 28.76 | 28.51 | 30.23 | |
Net income per share | 5.31 | 5.44 | 5.99 | 5.63 | 5.55 | |
Operating cash flow per share | 3.24 | 5.5 | 5.5 | 8.61 | 8.18 | |
Free cash flow per share | 1.87 | 4.13 | 4.13 | 6.85 | 6.92 | |
Cash per share | 3.03 | 4.1 | 4.03 | 4.17 | 4.19 | |
Book value per share | 33.12 | 30.56 | 30.56 | 79.21 | 69.22 | |
Tangible book value per share | -59.18 | -58.22 | -58.22 | -63.9 | -74.67 | |
Share holders equity per share | 33.12 | 30.56 | 30.56 | 79.21 | 69.22 | |
Interest debt per share | 103.01 | 104.78 | 104.78 | 90.45 | 99.79 | |
Market cap | 173.91B | 192.53B | 182.53B | 163.69B | 169.46B | |
Enterprise value | 194.93B | 213.79B | 203.79B | 182.34B | 190.18B | |
P/E ratio | 38.58 | 41.67 | 35.87 | 33.3 | 34.96 | |
Price to sales ratio | 28.69 | 31.52 | 29.88 | 26.29 | 25.65 | |
POCF ratio | 252.42 | 164.7 | 156.14 | 87.02 | 94.78 | |
PFCF ratio | 436.97 | 219.28 | 207.89 | 109.34 | 112.08 | |
P/B Ratio | 24.72 | 29.67 | 28.12 | 9.46 | 11.2 | |
PTB ratio | 24.72 | 29.67 | 28.12 | 9.46 | 11.2 | |
EV to sales | 32.16 | 35 | 33.36 | 29.29 | 28.79 | |
Enterprise value over EBITDA | 98.4 | 107.65 | 102.61 | 90.99 | 95.47 | |
EV to operating cash flow | 282.92 | 182.88 | 174.33 | 96.94 | 106.36 | |
EV to free cash flow | 489.79 | 243.5 | 232.1 | 121.81 | 125.78 | |
Earnings yield | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | |
Free cash flow yield | 0 | 0 | 0 | 0.01 | 0.01 | |
Debt to equity | 3.08 | 3.41 | 3.41 | 1.13 | 1.43 | |
Debt to assets | 0.61 | 0.63 | 0.63 | 0.41 | 0.45 | |
Net debt to EBITDA | 10.61 | 10.7 | 10.7 | 9.31 | 10.4 | |
Current ratio | 0.99 | 0.98 | 0.98 | 0.61 | 0.53 | |
Interest coverage | 7.12 | 12.16 | 12.16 | 8.8 | 10.47 | |
Income quality | 0.42 | 0.68 | 0.68 | 1.14 | 0.99 | |
Dividend Yield | 0.02 | 0.01 | 0.01 | 0 | 0.02 | |
Payout ratio | 2.83 | 0.92 | 0.83 | 0 | 2.97 | |
Sales general and administrative to revenue | 0.05 | 0.04 | 0.04 | 0.04 | 0.05 | |
Research and developement to revenue | 0.03 | 0.04 | 0.04 | 0.04 | 0.04 | |
Intangibles to total assets | 0.56 | 0.54 | 0.54 | 0.65 | 0.65 | |
Capex to operating cash flow | -0.42 | -0.25 | -0.25 | -0.2 | -0.15 | |
Capex to revenue | -0.05 | -0.05 | -0.05 | -0.06 | -0.04 | |
Capex to depreciation | -1.09 | -1.11 | -1.11 | -1.39 | -0.9 | |
Stock based compensation to revenue | 0 | 0 | 0 | 0.01 | 0 | |
Graham number | 62.88 | 61.14 | 64.17 | 100.14 | 92.95 | |
ROIC | 0.04 | 0.05 | 0.05 | 0.04 | 0.04 | |
Return on tangible assets | 0.07 | 0.07 | 0.08 | 0.07 | 0.07 | |
Graham Net | -107.83 | -108.08 | -107.86 | -114.25 | -125.84 | |
Working capital | -110M | -165M | -165M | -6.37B | -8.85B | |
Tangible asset value | -12.57B | -12.37B | -12.37B | -13.96B | -16.32B | |
Net current asset value | -18.95B | -18.92B | -18.92B | -20.92B | -23.4B | |
Invested capital | 3.08 | 3.41 | 3.41 | 1.13 | 1.43 | |
Average receivables | 3.95B | 3.97B | 4.03B | 4.19B | 4.35B | |
Average payables | 1.05B | 1.1B | 1.07B | 1.18B | 1.23B | |
Average inventory | 3.45B | 3.53B | 3.56B | 3.54B | 3.52B | |
Days sales outstanding | 58.7 | 58.76 | 60 | 62.38 | 59.84 | |
Days payables outstanding | 50.27 | 46.19 | 46.19 | 55.62 | 49.75 | |
Days of inventory on hand | 155.4 | 153.54 | 153.54 | 151.38 | 150.67 | |
Receivables turnover | 1.53 | 1.53 | 1.5 | 1.44 | 1.5 | |
Payables turnover | 1.79 | 1.95 | 1.95 | 1.62 | 1.81 | |
Inventory turnover | 0.58 | 0.59 | 0.59 | 0.59 | 0.6 | |
ROE | 0.16 | 0.18 | 0.2 | 0.07 | 0.08 | |
Capex per share | -1.37 | -1.37 | -1.37 | -1.76 | -1.26 |
CBHD.DE Frequently Asked Questions
What is Coloplast A/S stock symbol ?
Coloplast A/S is a DK stock and trading under the symbol CBHD.DE
What is Coloplast A/S stock quote today ?
Coloplast A/S stock price is $123.95 today.
Is Coloplast A/S stock public?
Yes, Coloplast A/S is a publicly traded company.